Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications

Inflammatory Bowel Diseases

Volumn 22, Issue 4, 2016, Pages 940-947

  Thompson, Kimberly D ^a,b   Connor, Susan J ^c,d   Walls, Danielle M ^e   Gollins, Jan ^f   Stewart, Sabrina K ^a   Bewtra, Meena ^g   Baumblatt, Geri L ^h   Holubar, Stefan D ^a   Greenup, Astrid Jane ^c   Sechi, Alexandra ^c   Girgis, Afaf ^d   Rubin, David T ⁱ   Siegel, Corey A ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e BDJ Solutions   (United States)

^f Delta Modelling   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h Emmi Solutions   (United States)

ⁱ UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

inflammatory bowel disease; quality of life in IBD; risk; shared decision making; ulcerative colitis

Indexed keywords

IMMUNOMODULATING AGENT; METHOTREXATE; STEROID; GASTROINTESTINAL AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER RISK; COLON RESECTION; COLORECTAL CANCER; DECISION MAKING; FEMALE; HEALTH SURVEY; HUMAN; ILEOSTOMY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ULCERATIVE COLITIS; UNITED STATES; YOUNG ADULT; ADVERSE DRUG REACTION; CHEMICALLY INDUCED; COLITIS, ULCERATIVE; COLORECTAL TUMOR; COLOSTOMY BAG; COMPLICATION; FOLLOW UP; PROGNOSIS; PSYCHOLOGY; QUESTIONNAIRE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLITIS, ULCERATIVE; COLONIC POUCHES; COLORECTAL NEOPLASMS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84962324281     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000740     Document Type: Article

References (30)

1. Siegel CA. Making therapeutic decisions in inflammatory bowel disease: the role of patients. Curr Opin Gastroenterol. 2009;25:334-338.
2. McCormick JB, Hammer RR, Farrell RM, et al. Experiences of patients with chronic gastrointestinal conditions: in their own words. Health Quality Life Outcomes. 2012;10:25.
3. Irvine EJ. Review article: patients? fears and unmet needs in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(suppl 4):54-59.
4. Levenstein S, Li Z, Almer S, et al. Cross-cultural variation in diseaserelated concerns among patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:1822-1830.
5. Drossman DA, Patrick DL, Mitchell CM, et al. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379-1386.
6. Bewtra M, Johnson FR. Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient. 2013;6:241-255.
7. Bewtra M. Lymphoma in inflammatory bowel disease and treatment decisions. Am J Gastroenterol. 2012;107:964-970.
8. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-Analysis. Gut. 2001;48:526-535.
9. Siegel CA, Marden SM, Persing SM, et al. Risk of lymphoma associated with combination anti-Tumor necrosis factor and immunomodulator therapy for the treatment of Crohn?s disease: a meta-Analysis. Clin Gastroenterol Hepatol. 2009;7:874-881.
10. O?Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009:CD001431.
11. Siegel CA, Levy LC, Mackenzie TA, et al. Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1-6.
12. O?Connor A, Edwards A. The role of decision aids in promoting evidence-based patient choice. In: Edwards A, Elwyn G, eds. Evidencebased Patient Choice. Oxford University Press; 2001.
13. Siegel CA, Lofland JH, Naim A, et al. Novel statistical approach to determine inflammatory bowel disease: Patients? perspectives on shared decision making. The Patient. 2016;9:79-89.
14. Baumgartner H, Suhan M, Padgett D. Patterns of affective reactions to advertisements: the integration of moment-To-moment responses into overall judgments. J Mark Res. 1997;34:219-232.
15. Woltman Elpers JL, Wedel M, Pieters RG. Why do consumers stop viewing television commercials?. Two experiments on the influence of moment-To-moment entertainment and information value. J Mark Res. 2003;40:437-453.
16. Woltman Elpers JL, Mukherjee A, Hoyer WD. Humor in television advertising: a moment-To-moment analysis. J Consum Res. 2004;31:592-598.
17. Jarman JW. Political affiliation and presidential debates a real-Time analysis of the effect of the arguments used in the presidential debates. Am Behav Sci. 2005;49:229-242.
18. Tedesco JC. Televised political advertising effects: evaluating responses during the 2000 Robb-Allen senatorial election. J Advertising. 2002;31:37-48.
19. Siegel CA, Lofland JH, Naim A, et al. Gastroenterologists? views of shared decision making for patients with inflammatory bowel disease. Dig Dis Sci. 2015;60:2636-2645.
20. Johnson FR, Van Houtven G, Ozdemir S, et al. Multiple sclerosis patients? benefit-risk preferences: serious adverse event risks versus treatment efficacy. J Neurol. 2009;256:554-562.
21. Barton JL. Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy. Patient Prefer Adherence. 2009;3: 335-344.
22. Lee CN, Dominik R, Levin CA, et al. Development of instruments to measure the quality of breast cancer treatment decisions. Health Expect. 2010;13:258-272.
23. van Eijk-Hustings Y, Ammerlaan J, Voorneveld-Nieuwenhuis H, et al. Patients? needs and expectations with regard to rheumatology nursing care: results of multicentre focus group interviews. Ann Rheum Dis. 2013;72:831-835.
24. Garfield S, Smith F, Francis SA, et al. Can patients? preferences for involvement in decision-making regarding the use of medicines be predicted?. Patient Educ Couns. 2007;66:361-367.
25. Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277:1485-1492.
26. Baars JE, Markus T, Kuipers EJ, et al. Patients? preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-Empowerment study. Digestion. 2010;81:113-119.
27. Keeton RL, Mikocka-Walus A, Andrews JM. Concerns and worries in people living with inflammatory bowel disease (IBD): A mixed methods study. Journal of Psychosomatic Research. 2015;78:573-578.
28. Johnson FR, Ozdemir S, Mansfield C, et al. Crohn?s disease patients? riskbenefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology. 2007;133:769-779.
29. Roberts S, Williams J, Yeates D, et al. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn?s disease: record linkage studies. BMJ. 2007;17:1033-3.
30. Randall J, Singh B, Warren B, et al. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications. Br J Surg. 2010;97:404-409.